Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,005.00
Bid: 7,021.00
Ask: 7,022.00
Change: 147.00 (2.14%)
Spread: 1.00 (0.01%)
Open: 6,927.00
High: 7,023.00
Low: 6,849.00
Yest. Close: 6,858.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Circassia Pharma To Acquire Full US Tudorza Rights From AstraZeneca

LONDON (Alliance News) - Circassia Pharmaceuticals PLC said Tuesday it plans to exercise its option to acquire the full US rights to the Tudorza chronic obstructive pulmonary disease drug from to

11 Dec 18 13:15

Dr Reddy's Launches Over-The-Counter Version Of AstraZeneca's Prilosec

NEW DELHI (Alliance News) - Dr. Reddy's Laboratories Ltd announced the launch of Omeprazole Delayed-Release Tablets, 20 mg, an over-the-counter store-brand equivalent of Prilosec OTC Tablets,

11 Dec 18 06:50

TOP NEWS: Imfinzi Fails To Meet Primary Endpoint In AstraZeneca Trial

LONDON (Alliance News) - Pharmaceticals form AstraZeneca PLC on Friday said its phase three Eagle trial of Imfinzi in advanced head and neck cancer patients failed to meet its primary study alone,

7 Dec 18 08:36

AstraZeneca's Imfinzi fails to reach endpoint in difficult trial

(Sharecast News) - AstraZeneca and its global biologics research and development arm MedImmune announced overall survival results for the Phase III EAGLE trial of Imfinzi (durvalumab) on Friday.

7 Dec 18 07:24

European Markets Tumble On Weak Oil Prices And Trade Worries

BRUSSELS/FRANKFURT/PARIS (Alliance News) - The European markets ended Thursday's session sharply lower, extending the losses from the previous two days. Falling crude oil prices and the

6 Dec 18 17:32

AstraZeneca offloads ciclesonide rights to Covis in $350m deal

(Sharecast News) - AstraZeneca has completed an agreement with Covis Pharma to sell its rights to the medicines Alvesco (ciclesonide), used for the treatment of persistent asthma, and Omnaris and Zetonna (ciclesonide), used for the treatment of nasal symptoms associated with rhinitis.

6 Dec 18 07:23

Majedie Investments Net Assets Fall As It Hikes Payout, Redeems Debt

LONDON (Alliance News) - Majedie Investments PLC on Wednesday reported a decrease in net asset value over its financial year due to making higher dividend payouts and redeeming debentures, as its

5 Dec 18 11:56

AstraZeneca's Long-Term Calquence Leukaemia Study Results Encouraging

LONDON (Alliance News) - AstraZeneca PLC on Monday presented long-term follow-up data from a trial of Calquence in chronic lymphocytic leukaemia patients which showed a sustained a meaningful to a

4 Dec 18 18:27

TOP NEWS: AstraZeneca Sells Nexium And Vimovo Rights To Grunenthal

LONDON (Alliance News) - AstraZeneca PLC said Monday it has completed an agreement to divest the prescription medicine rights to Nexium in Europe and the global rights, excluding the US and Japan,

3 Dec 18 08:12

AstraZeneca offloads rights to Nexium and Vimovo

(Sharecast News) - AstraZeneca has completed an agreement to divest the prescription medicine rights to Nexium (esomeprazole) in Europe, as well as the global rights - excluding the US and Japan - to Vimovo (naproxen/esomeprazole), to Grunenthal, it announced on Monday.

3 Dec 18 07:25

AstraZeneca To Work With Belgian Diagnostics Firm On Lung Cancer Test

LONDON (Alliance News) - Belgium-based diagnostics firm Biocartis Group NV on Thursday unveiled an agreement with AstraZeneca PLC in which the two will work to improve the speed of lung cancer be

29 Nov 18 10:12

TOP NEWS: AstraZeneca Gets Orphan Drug Designation For Fasenra

LONDON (Alliance News) - AstraZeneca PLC said Monday the US Food & Drug Administration has granted orphan drug designation to Fasenra for the treatment of eosinophilic granulomatosis with a to

26 Nov 18 08:21

US FDA grants orphan status for AstraZeneca's Fasenra

(Sharecast News) - AstraZeneca on Monday said its Fasenra treatment for the autoimmune disease eosinophilic granulomatosis with polyangiitis (EGPA) had been granted Orphan Drug Designation (ODD) by the US Food and Drug Administration (FDA).

26 Nov 18 07:18

Redx Pharma Posts Large Annual Loss, Appoints Astra Executive As CFO

LONDON (Alliance News) - Redx Pharma PLC on Monday posted a large loss due to the absence of a big exceptional disposal gain seen a year before and said that it has appointed James Mead as its new

19 Nov 18 13:07

Monday broker round-up

(Sharecast News) - Sainsbury: Berenberg reiterates buy with a target price of 369p.

19 Nov 18 12:13

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.